Clinical Trials · NCT00717457
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Hoffmann-La Roche
- Enrollment
- 1,189
- Start date
- Jul 2008
- Locations
- 216 sites, 26 countries
- Primary endpoint
- Change in HbA1c